[19vol19no1-04] ôÃßÀ¶ÇÕÀÌ ÁøÇàµÈ °­Á÷¼º ôÃß¿°¿¡ ÀÇ·á±â°ø°ú Çѹæ¿ä¹ýÀ» Àû¿ëÇÑ Áõ·Ê º¸°í ÀÌÀº¹Ì ¿Ü3
241 ÀÌÀçÈï 2020.02.05 561  19vol19no1-04-kor.enw (1 KB), 19vol19no1-04-eng.enw (1 KB), 19vol19no1-04-LeeEM.pdf (994 KB)
[Àοë]

ÀÌÀº¹Ì, Á¤ÀçÈÆ, ³ª»ï½Ä, ¾ÈÈƸð. ôÃßÀ¶ÇÕÀÌ ÁøÇàµÈ °­Á÷¼º ôÃß¿°¿¡ ÀÇ·á±â°ø°ú Çѹæ¿ä¹ýÀ» Àû¿ëÇÑ Áõ·Ê º¸°í. ì¢ÖûѨÍí. 2019;19(1):99-115
Eun Mi Lee, Jae Hun Jung, Sam Sik Na, Hun Mo Ahn. A Case Report of Medical Gi-Gong and Korean Medical Therapy for advanced Ankylosing Spondylitis with spinal fusion. Medical Gigong. 2019;19(1):99-115

---------
[°³°ý]

ì¢ÖûѨÍí
MEDICAL GIGONG
Vol.19. No.1. 2019.12.31.

ôÃßÀ¶ÇÕÀÌ ÁøÇàµÈ °­Á÷¼º ôÃß¿°¿¡ ÀÇ·á±â°ø°ú Çѹæ¿ä¹ýÀ» Àû¿ëÇÑ Áõ·Ê º¸°í

ÀÌÀº¹Ì*•Á¤ÀçÈÆ*•³ª»ï½Ä*•¾ÈÈƸð*

* : ´ëÇÑÀÇ·á±â°øÇÐȸ*

---------
[Abstract]

A Case Report of Medical Gi-Gong and Korean Medical Therapy for advanced Ankylosing Spondylitis with spinal fusion

Eun Mi Lee*, Jae Hun Jung*, Sam Sik Na*, Hun Mo Ahn*
* : The Member of the Korean Academy of Medical Gi-Gong

Introduction : In patient with ankylosing spondylitis, when bone formation progresses, spinal fusion occurs and joint motion is severely limited. We performed Medical Gi-gong and Korean medical therapies in patient with advanced ankylosing spondylitis with spinal fusion.

Case : 46-year-old male with extensive spinal fusion at the cervical and lumbar spine complains of back pain, hip pain, joint stiffness, eye pain, and digestive problems. HLA-B27 (+), mSASSS is 70. Medical Gi-gong was done 311 days for 340 days. Acupuncture, cupping, and manual treatment were performed once every 5.9 days for one year. BASDAI improved from 5.3 to 4.3, BASFI from 4.3 to 3.7, and BASMI from 6.8 to 5.8. mSASSS did not change.

Conclusions : Patients with advanced ankylosing spondylitis were treated with Medical Gigong and Korean medical therapies to achieve a slight improvement.

---------
* Keywords : ankylosing spondylitis, spinal fusion, Medical Gigong, BASMI, °­Á÷¼º ôÃß¿°, ÀÇ·á±â°ø

---------
[¸ñÂ÷]

Abstract

¥°. ßýÖå

¥±. Áõ·Ê
1. ÃÊÁø »çÇ×
1) ¿¹Áø »çÇ×
2) ¹®Áø »çÇ×
2. °Ë»ç ¼Ò°ß
1) ÀÓ»ó °Ë»ç ¼Ò°ß – (2018³â 12¿ù 09ÀÏ)
2) ¹æ»ç¼± °Ë»ç¼Ò°ß
3. Ä¡·á ¹æ¹ý
1) öÜ϶ ö½Öû
2) å·Úª ö½Öû
3) ì¢ÖûѨÍí
4) ¼ö±â¿ä¹ý
4. Ä¡·á °á°ú
1) ESR, CRP, BASDAI, BASFI, mSASSS º¯È­
2) BASMIÀÇ º¯È­

¥². ÍÅóÌ

¥³. Ì¿Öå

¥´. óÑÍÅÙþúÌ

---------
[¼­·Ð]

°­Á÷¼ºÃ´Ãß¿°(ankylosing spondylitis)Àº ÁøÇ༺ÀÇ Æ¯Â¡ÀÌ ÀÖ´Â ¸¸¼º ¿°Áõ¼º ÁúȯÀ¸·Î Ã༺ ôÃß °üÀý¿°(axial spondyloarthritis)ÀÇ °¡Àå ÁÖµÈ ÁúȯÀÌ´Ù[1]. ÁÖ¿ä ¿µÇâ ºÎÀ§´Â °ñ¹Ý°ú Ã༺ °üÀýÀΠôÃßÀÌ¸ç ¸»ÃÊ°üÀý, ÇǺÎ, ´«, ¶Ç´Â Àå¿¡ ¿µÇâÀ» ÁÙ ¼ö ÀÖÀ¸¸ç ½ÉÇ÷°ü ¶Ç´Â Æó Áõ»óÀÇ À§ÇèÀ» Áõ°¡½ÃŲ´Ù[2]. °­Á÷¼º ôÃß¿°ÀÇ º´¸®ÇÐÀûÀΠƯ¡Àº õÀå°üÀý¿°(sacroiliitis)°ú ôÃß¿° (spondylitis)À¸·Î ÀÎÇÑ ¿°Áõ¼º ¿äÅë, ±×¸®°í °üÀý °­Á÷(Ankylosis)À» À¯¹ßÇÏ´Â Àδë°ñÁõ½Ä(syndesmophytes)À» Çü¼ºÇÑ´Ù´Â °ÍÀÌ´Ù. Àδë°ñÁõ½ÄÀÇ Çü¼º, °üÀý °­Á÷°ú °°Àº ôÃßÀÇ ¹æ»ç¼±ÇÐÀû º¯È­´Â Áúº´ÀÇ À¯º´ ±â°£°ú ¿¬°üÀÌ ÀÖÀ¸¸ç ôÃßÀÇ ¿îµ¿¼ºÀ» °¨¼Ò½ÃŲ´Ù[3]. °üÀý °­Á÷ÀÌ ÀÌ·ç¾îÁø ôÃß °üÀýÀº °¡µ¿ÀÌ ºÒ°¡´ÉÇÏ¿© ¿îµ¿¿¡ °áÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ½Åü È°µ¿´É·ÂÀ» ÈѼÕÇÏ¿© ½É°¢ÇÑ Àå¾Ö¿Í ÀÛ¾÷ ´É·Â ¼Õ½ÇÀ» À¯¹ßÇÑ´Ù.
°­Á÷¼º ôÃß¿°À» Ä¡·áÇÏ´Â ¸ñÇ¥´Â ôÃßÀÇ ¿°ÁõÀ¸·Î ÀÎÇÑ ÅëÁõÀÇ °ü¸®¿Í ¹Ù¸¥ ÀÚ¼¼¿Í ¿îµ¿¹üÀ§¸¦ À¯ÁöÇÏ¸ç ¹æ»ç¼±ÇÐÀû ôÃßÀÇ º¯ÇüÀ» ¿¹¹æÇÏ´Â °ÍÀÌ °ü°ÇÀÌ µÈ´Ù[4]. ¾à¹°¿ä¹ýÀ¸·Î´Â ºñ½ºÅ×·ÎÀ̵强 Ç׿°Á¦¿Í Á¾¾ç±«»çÀÎÀÚ ÀúÇØÁ¦°¡ »ç¿ëµÇ°í ÀÖÀ¸¸ç ÃÖ±Ù¿¡´Â ¿°Áõ°ú °ñ»ý¼º¿¡ °ü¿©ÇÏ´Â IL-17°ú IL-23¿¡ ´ëÇÑ ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ´Ù. ºñ½ºÅ×·ÎÀ̵强 Ç׿°Á¦(nonsteroidal anti-inflammatory drugs, NSAIDs)ÀÇ °æ¿ì ÅëÁõ¿ÏÈ­¿Í ôÃ߿¼ºÀ» Áõ°¡½ÃÅ°´Â È¿°ú°¡ ÀÖÀ¸¸ç °­Á÷À» ¿¹¹æÇÏ´Â ¾à¹°·Î ±â´ëµÇ¸ç À§Àå°ü, ½ÉÇ÷°ü °èÅëÀÇ ºÎÀÛ¿ëÀ» °í·ÁÇØ¾ß ÇÑ´Ù[5, 6]. Á¾¾ç±«»çÀÎÀÚ((tumor necrosis factor, TNF)-¥á ÀúÇØÁ¦´Â ƯÈ÷ Áúº´È°¼ºµµ°¡ ½ÉÇÑ °æ¿ì³ª µÎ °³ ÀÌ»óÀÇ NSAIDs ¿¡ È¿°ú¸¦ º¸ÀÌÁö ¾Ê´Â °æ¿ì¿¡ À¯È¿ÇÏ°Ô ÃßõµÇ°í ÀÖÀ¸³ª °ñ Áõ½ÄÀ» ÁÙ¿©ÁÖÁö´Â ¸øÇÏ´Â °ÍÀ¸·Î º¸°íµÇ°í ÀÖÀ¸¸ç ÇǺΠÀÌ»ó¹ÝÀÀ°ú °áÇÙ µîÀÇ °¨¿°¿¡ À¯ÀÇÇØ¾ß ÇÑ´Ù[7]. ºñ¾à¹° ¿ä¹ýÀ¸·Î´Â ¸ÅÀÏ ¾þµå¸° ÀÚ¼¼¸¦ ÃëÇÏ°í µüµüÇÑ Ä§»óÀ» »ç¿ëÇÏ´Â °ÍÀÌ ±ÇÀåµÇ¸ç »ó´ã°ú ±³À°, Áõ»ó¿¡ ¸Â´Â ÀûÀýÇÑ ¿îµ¿°ú ÀçÈ°Ä¡·á°¡ ±âº»ÀûÀ¸·Î ÃßõµÇ°í ÀÖÀ¸¸ç[8] È¿°úÀûÀÎ ¿îµ¿¹ý¿¡ ´ëÇÑ ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ´Ù[9]
°­Á÷¼ºÃ´Ãß¿°¿¡ ´ëÇÑ ÇÑÀÇÇÐÀû °ßÇØ´Â ÍéÝöñû(°ñºñÁõ)[10] ¶Ç´Â ô±Ë­(ô°­)À¸·Î[11] º¸¾ÒÀ¸¸ç Ä¡·á¹æ¹ýÀ¸·Î´Â ÜÍëäñýð¥·Î ãìúȸ¦ Ä¡·áÇϰųª[12] ½ÉÈäºÎÀÇ ¿­À» ³»¸®±â À§ÇØ »ýÁöȲ, ¼®°í µîÀ» »ç¿ëÇϰųª[13] üÀúìËÛåÜ, ËÛù¦ã­ã¥ ò­÷ÔÇϴ ó¹æÀ» »ç¿ëÇÏ¿´´Ù[14, 15]. ¶ÇÇÑ ¸¸¼ºÀûÀ¸·Î ¼ÒÈ­Àå¾Ö°¡ ÀÖÀ¸¹Ç·Î Þ¡êÖñý𥸦 »ç¿ëÇÏ¿´´Ù[16]. Áï ù»õ¥ÀÇ ãìâ©¿¡ ´ëÇÑ Ã³¹æ, ß¾õ¥ÀÇ ûý¿¡ ´ëÇÑ Ã³¹æ, ±×¸®°í ñéõ¥ Þ¡êÖÀÇ Ã³¹æÀ» »ç¿ëÇßÀ¸¸ç ÀÌ´Â â©ã°ûý˽ÀÌ Àß ÀÌ·ç¾îÁöÁö ¾Ê´Â °ÍÀ¸·Î °¡¸§ÇÒ ¼ö ÀÖ´Ù.
ÀÇ·á±â°øÀ̶õ ÇÑÀÇÇÐÀÇ ¿ø¸® ÇÏ¿¡ ±â°øÀ» Áúº´ÀÇ Áø´Ü, Ä¡·á ¹× ¿¹¹æ¿¡ Àû±ØÀûÀ¸·Î È°¿ëÇÏ´Â ±â¼úÀÎ ±â°ø¿ä¹ý¿¡ ´ëÇÏ¿© ¿¬±¸ÇÏ´Â Çй®À¸·Î °í´ë·ÎºÎÅÍ Àü·¡µÈ °¢Á¾ ±â°ø°ø¹ý°ú Çö´ë¿¡ »õ·ÎÀÌ °³¹ßµÈ °¢Á¾ ±â°ø°ø¹ý¿¡ ´ëÇÏ¿© ±× ¿ª»ç¿Í ±âÃÊÀÌ·Ð, ¼ö·Ã¹æ¹ý, ÀÛ¿ë¿ø¸® µîÀ» ¿¬±¸ÇÏ°í, À̸¦ ÀÓ»ó °¢ °ú¿¡¼­ ȯÀÚÀÇ Áø´Ü, Ä¡·á ¹× Áúº´ÀÇ ¿¹¹æ¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖµµ·Ï ¿¬±¸ÇÏ´Â Çй®ÀÌ´Ù[17].
±× µ¿¾È °­Á÷¼º ôÃß¿° ȯÀÚ¿¡ ´ëÇØ ÇѹæÄ¡·á¸¦ Àû¿ëÇÑ Áõ·Êº¸°í´Â ÃʱâÀÇ °­Á÷¼ºÃ´Ãß¿°À̰ųª ´Ü±â°£ µ¿¾ÈÀÇ Ä¡·á Áõ·Ê¿´°í °üÀý°­Á÷ÀÌ ÁøÇàµÈ °­Á÷¼º ôÃß¿° ȯÀÚ¸¦ Àå±â°£¿¡ °ÉÃÄ Ä¡·á °ü¸®ÇÑ ¿¹´Â ¾ÆÁ÷ ¹ßÇ¥µÇÁö ¾Ê¾Ò´Ù. ¶ÇÇÑ °Ç°­º¸Çè½É»çÆò°¡¿øÀÇ Áúº´Åë°è¿¡ µû¸£¸é, °­Á÷¼ºÃ´Ãß¿° ȯÀÚ ¼ö´Â 2010³â 3¸¸1802¸í¿¡¼­ 2018³â¿¡´Â 4¸¸3686¸íÀ¸·Î Áõ°¡Çϴµ¥ ¹ÝÇØ Çѹæ ÀÇ·á±â°ü¿¡¼­ Ä¡·á¹ÞÀº ȯÀÚ´Â 2,262¸íÀ¸·ÎÁÖ ). °­Á÷¼º ôÃß¿°ÀÇ Ä¡·á¿Í ¿¬±¸¿¡ ÇÑÀÇÇÐÀûÀÎ Á¢±ÙÀÌ ¸¹ÀÌ ºÎÁ·ÇÑ »óȲÀÌ´Ù.
º» ¿¬±¸ÁøÀº ôÃß °­Á÷ÀÌ ¿äÃß¿Í °æÃß¿¡ »ó´çÈ÷ ÁøÇàµÈ ¸¸¼º °­Á÷¼º ôÃß¿° ȯÀÚ¸¦ ÀÇ·á±â°ø°ú Çѹæ¿ä¹ýÀ¸·Î 1³âµ¿¾È °ü¸®ÇÏ¿© ÀÇ¹Ì ÀÖ´Â °æ°ú¸¦ º¸¿´±â¿¡ ȯÀÚÀÇ µ¿ÀǸ¦ ¹Þ¾Æ À̸¦ º¸°íÇÑ´Ù.
µ¡¸»

¿ì415-865/ °æ±âµµ ±èÆ÷½Ã ÅëÁøÀ¾ ¸¶¼Û¸® 160-10 ´ëÇÑÀÇ·á±â°øÇÐȸ Tel 031-999-2222 / Fax 02-999-2200
Copyright(c) 2003 ´ëÇÑÀÇ·á±â°øÇÐȸ. All rights reserved.